Telehealth ServicesNCT06656520
Impact of Telehealth Care
An observational study of Telehealth Services and Telehealth, run by Pei-Hung Liao.
Trial summary
Heart failure is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program could address these challenges while improving patient outcomes. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Telehealth Services, Telehealth
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 2 Oct 2023to 31 Oct 2026
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Inpatients diagnosed with heart failure were enrolled, with patients automatically selected daily by the electronic medical record system. A list of ward visits was obtained based on the first three digits of the International Classification of Diseases 10th edition diagnosis codes; the ICD-10 code I50 was applied for selection.
Who may be able to join
- Inpatients diagnosed with heart failure were enrolled, with patients automatically selected daily by the electronic medical record system. A list of ward visits was obtained based on the first three digits of the International Classification of Diseases 10th edition diagnosis codes; the ICD-10 code I50 was applied for selection.
Who cannot join
- Other diagnosis
About this study
Official title: Impact of Telehealth Care on Clinical Outcomes in Heart Failure Patients
Heart failure is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program could address these challenges while improving patient outcomes.
Read the detailed description
Telemonitoring for heart failure patients reduces all-cause and cardiovascular mortality by enabling early intervention during clinical deterioration, improving outcomes even for those recently discharged. Moreover, a reduction in the percentage of days lost due to unplanned cardiovascular hospital admissions is evident. Furthermore, the rapid expansion of telehealth care and telemedicine services during the COVID-19 pandemic optimized the management and care quality of heart failure patients through telemonitoring .
- Conditions
- Telehealth Services, Telehealth
- Keywords
- Telehealth, heart failure, rehospitalization, mortality
- Medical subject headings
- Heart Failure
What is being measured
The primary outcome is the main question the study is designed to answer.
mortality and rehospitalization rates
analyze the one-year all-cause mortality and rehospitalization rates in patients with and without telehealth care while examining cardiovascular mortality and rehospitalization rates simultaneously.
Measured: After discharge one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2024
- Study start2 Oct 2023
- Primary completion2 Oct 2026 (estimated)
- Study completion31 Oct 2026 (estimated)
Why it stopped: A retrospective observational study was conducted using electronic medical record data
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Telehealth ServicesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Pei-Hung Liao
- Sponsor type
- University, hospital or other
- Collaborators
- Mackay Memorial Hospital, National Taipei University of Nursing and Health Sciences
- Responsible party
- Sponsor-investigator, Pei-Hung Liao, National Taipei University of Nursing and Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06656520
- Sponsor's protocol ID
- 23MMHIS219e
- Status last verified
- Oct 2024
- First submitted
- 22 Oct 2024
- Last updated
- 24 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Telehealth Care on Clinical Outcomes in Heart Failure Patients
- ClinicalTrials.gov ID
- NCT06656520
- Acronym / sponsor ID
- 23MMHIS219e
- Conditions
- Telehealth Services, Telehealth
- Keywords
- Telehealth, heart failure, rehospitalization, mortality
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: A retrospective observational study was conducted using electronic medical record data
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Pei-Hung LiaoUniversity, hospital or other
- Collaborators
- Mackay Memorial Hospital, National Taipei University of Nursing and Health Sciences
- Study start
- 2 Oct 2023 (actual)
- Primary completion
- 2 Oct 2026 (estimated)
- Study completion
- 31 Oct 2026 (estimated)
- First posted
- 24 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Heart failure is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program could address these challenges while improving patient outcomes.
Detailed description
Telemonitoring for heart failure patients reduces all-cause and cardiovascular mortality by enabling early intervention during clinical deterioration, improving outcomes even for those recently discharged. Moreover, a reduction in the percentage of days lost due to unplanned cardiovascular hospital admissions is evident. Furthermore, the rapid expansion of telehealth care and telemedicine services during the COVID-19 pandemic optimized the management and care quality of heart failure patients through telemonitoring .
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Target follow-up
- 1 Month
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Inpatients diagnosed with heart failure were enrolled, with patients automatically selected daily by the electronic medical record system. A list of ward visits was obtained based on the first three digits of the International Classification of Diseases 10th edition diagnosis codes; the ICD-10 code I50 was applied for selection.
Key inclusion criteria (1 listed)
- Inpatients diagnosed with heart failure were enrolled, with patients automatically selected daily by the electronic medical record system. A list of ward visits was obtained based on the first three digits of the International Classification of Diseases 10th edition diagnosis codes; the ICD-10 code I50 was applied for selection.
Key exclusion criteria (1 listed)
- Other diagnosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
mortality and rehospitalization rates
Time frame: After discharge one year
analyze the one-year all-cause mortality and rehospitalization rates in patients with and without telehealth care while examining cardiovascular mortality and rehospitalization rates simultaneously.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Telehealth Services
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Recruiting
The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care
Digital Health, Maternal Health Services
Recruiting
The ENHANCE Project Toolkit
Substance Related Disorder, Drug Overdose
RecruitingPhase 2
Rehabilitation of Airway Protection in Parkinson's Disease
Parkinson Disease, Dysphagia
Not yet recruiting
Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV
Hypertension, Blood Pressure Monitoring
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Telehealth Services and Telehealth, run by Pei-Hung Liao.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 24 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mortality and rehospitalization rates (time frame: After discharge one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2024.